Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells (Q37809460)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 15, 2010

Language	Label	Description	Also known as
English	Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells	scientific article published on November 15, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

0 references

monoclonal antibody

1 reference

based on heuristic

inferred from title

Ravindra Majeti

1

object named as

R. Majeti

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21076471

26 August 2024

language of work or name

0 references

publication date

15 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://www.nature.com/articles/onc2010511.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21076471

26 August 2024

https://www.nature.com/articles/onc2010511.pdf

Portable Document Format

1 reference

10.1038/ONC.2010.511

https://api.crossref.org/works/10.1038/ONC.2010.511

26 August 2024

https://www.nature.com/articles/onc2010511

1 reference

10.1038/ONC.2010.511

https://api.crossref.org/works/10.1038/ONC.2010.511

26 August 2024

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1009-1019

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

The SIRP family of receptors and immune regulation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Isolation of a candidate human hematopoietic stem-cell population

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Integrin-associated protein (CD47) and its ligands

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Treatment of older patients with acute myeloid leukemia--new agents

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Expression of Thy-1 on human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Cancer stem cells: models and concepts

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Stem cell concepts renew cancer research

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

The roles of FLT3 in hematopoiesis and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Internal tandem duplications of the FLT3 gene are present in leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Role of CD47 as a marker of self on red blood cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Efficient tumour formation by single human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Humanized mice in translational biomedical research

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

The cancer stem cell hypothesis: a work in progress

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Interleukin-3 receptor in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Monoclonal antibody therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Cancer immunology

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

The molecular basis of leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Tumor growth need not be driven by rare cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Identifiers

10.1038/ONC.2010.511

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37809460&oldid=2239087864"